Good Samaritan Introduces Cutting-Edge Robotic-Assisted Lung Biopsy Technology

Good Samaritan is proud to announce the addition of the Ion Endoluminal System, a state-of-the-art robotic-assisted platform for minimally invasive lung biopsies. This innovative technology enhances precision and access when diagnosing lung nodules, potentially leading to earlier detection and treatment of lung cancer.

Lung cancer remains the leading cause of cancer-related deaths, but early detection significantly improves survival rates. The Ion Endoluminal System, developed by Intuitive—the makers of the da Vinci Surgical System—offers a revolutionary approach to lung biopsies. By allowing physicians to navigate deep into the lungs with enhanced stability and precision, this technology enables tissue sampling from hard-to-reach nodules while reducing the need for more invasive procedures.

“With the introduction of Ion, we can provide our patients with a more advanced and minimally invasive approach to lung biopsy,” said Good Samaritan Pulmonologist Johnathon Grant, DO. “This means greater accuracy, faster results, and ultimately, better outcomes for those at risk of lung cancer.”

Compared to traditional bronchoscopy methods, the Ion system offers increased reach and flexibility, allowing for more successful biopsies with fewer complications. This means patients can receive a diagnosis sooner, helping them and their care teams make informed treatment decisions more quickly.

Patients can learn more about this groundbreaking technology by visiting gshvin.org/ion.